相关实验视频
Updated: Jul 13, 2025

08:39
Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
50.0K
在大肠炎的小鼠模型中,具有光作用的5-HT4受体激动剂的保护作用
Molly Hurd1, Melody M Haag1, Matthew J Kwasnik1
1Department of Neurological Sciences, The University of Vermont, Burlington, Vermont, USA.
Neurogastroenterology and motility
|October 13, 2023
概括
光作用的5-HT4R激动剂通过增强上皮质愈合来有效治疗结肠炎. 这些化合物与可吸收药物相当,可能有助于治疗炎症性肠病.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 5-西胺4受体 (5-HT4 Rs) 存在于结肠表皮.
- 发光激动剂增强运动性,减轻疼痛,并防止结肠炎症.
研究的目的:
- 评估光效作用的5-HT4R激动剂 (5HT4-LA1) 是否有效治疗结肠炎.
- 为了将其疗效与之前研究的可吸收化合物进行比较.
主要方法:
- 使用德克斯硫酸盐 (DSS),TNBS和IL-10淘汰赛的大肠炎小鼠模型.
- 用5HT4-LA1透过阴囊进行预防和恢复,有或没有抗剂.
- 评估疾病活动指数 (DAI),组织学,伤口愈合和便水含量.
主要成果:
- 5HT4-LA1淋浴剂减弱了结肠炎的发展和加速恢复.
- 疗效取决于5-HT4 R的存在,因为淘汰赛小鼠没有显示任何益处.
- 5HT4-LA1增强了Caco-2细胞迁移,表明伤口愈合加速,而不会增加便中的水含量.
结论:
- 灯光受限的5-HT4R激动剂在治疗活性结肠炎方面是有效的,与可吸收药物相比.
- 这些激动剂显示出作为炎症性肠病 (IBD) 的辅助疗法的潜力,以促进上皮质愈合.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.1K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
953
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
276
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
276
Drugs for Treatment of Ulcerative Colitis in IBD
152
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
152